Table 5.
Comparison of deep grey matter (DGM) inflammation, neurodegeneration and iron density in relation to the cortex and white matter
MS NADGM | MS normal-appearing cortex | MS normal-appearing white matter | ||
---|---|---|---|---|
CD3-positive T cells | Median | 1.7 | 1.7 | 2.2 |
Min.−Max. | 0–6.6 | 0–5.2 | 0–12.2 | |
CD68-reactive macrophages and microglia/mm2 | Median | 150.8 | 145.8 | 264.8* |
Min.−Max. | 63.1–310.8 | 66–217 | 85.1–505.2 | |
IBA-1-reactive macrophages and microglia /mm | Median | 222.4 | 267.4 | 390.6* |
Min.−Max. | 35.6–697.9 | 45.1–817.7 | 111.1–796.9 | |
iNOS-reactive macrophages and microglia/mm2 | Median | 76.7 | 17.4* | 9.6* |
Min.−Max. | 32.1–174.8 | 0–158 | 0–107.6 | |
p22-Reactive macrophages and microglia/mm2 | Median | 347.4 | 383.7 | 418.8 |
Min.−Max. | 122.4–704.3 | 125–788.2 | 177.1–793.4 | |
% Of p22-positive area | Median | 1.2 | 1.4 | 1.7 |
Min.−Max. | 0–7.3 | 0.1–7.7 | 0.2–7 | |
APP-reactive neuronal cell bodies/mm2 | Median | 0.3 | 0 | |
Min.−Max. | 0–3.5 | 0–2.5 | ||
APP-reactive axonal spheroids/ mm2 | Median | 3 | 0 | 0* |
Min.−Max. | 0–55.6 | 0–8.7 | 0–34.7 | |
% E06-reactive neurons | Median | 69.1 | 33.9* | |
Min.−Max. | 19.8–99.0 | 2.5–86.7 | ||
E06-reactive axonal spheroids/mm2 | Median | 1.5 | 0* | 0* |
Min.−Max. | 0–224 | 0–7.4 | 0–2.6 | |
E06-reactive thin cellular processes/mm2 | Median | 5.4 | 0* | 0* |
Min.–Max. | 0–150.5 | 0–12.2 | 0–194.4 | |
E06-reactive oligodendrocytes/mm2 | Median | 15.2 | 0* | 0* |
Min.−Max. | 0–72.1 | 0–34.7 | 0–128.5 | |
E06-reactive lipofuscin/mm2 | Median | 29.2 | 17.4* | 3.5* |
Min.−Max. | 1.7–88.5 | 0–34.7 | 0–29.5 | |
% E06-positive area | Median | 3.5 | 0.1* | 0.6* |
Min.−Max. | 0.1–29.7 | 0–4.6 | 0–29 | |
Oxidised DNA-reactive nuclei/mm2 | Median | 3.5 | 0* | 0* |
Min.−Max. | 0–19.7 | 0–15.6 | 0–12.2 | |
Iron density | Median | 654.5 | 306.3* | 330.3* |
Min.−Max. | 391.6–1031.2 | 238.9–377.7 | 222.3–733.9 |
This table depicts a comparison among the extent of inflammatory infiltrates, neurodegeneration and iron density in the normal-appearing deep grey matter (NADGM) (n=30) and the normal-appearing cortex (n=11) and white matter (n=24) of patients with MS. The values represent the median values and range.
*Significant p values after correction for multiple testing in comparison with NADGM.
Microglia and macrophage counts are pooled in order to facilitate the description. In patients with MS, normal-appearing white matter in the internal capsule expressed significantly more CD68 (p<0.001) and IBA-1 (p=0.027) compared with those in the NADGM. All evaluated E06-reactive structures, such as neurons (p<0.001), axonal spheroids (p=0.015 and p=0.002, respectively), thin cellular processes (p=0.014 and p=0.008, respectively), oligodendrocytes (p<0.001 and p<0.001, respectively) and lipofuscin (p=0.021 and p<0.001, respectively), were expressed at significantly higher levels in NADGM than in normal-appearing white matter or cortex. Similarly, the levels of oxidised DNA-reactive nuclei (p=0.039 and p<0.001, respectively) and the percentage of area data (p<0.001 and p=0.004, respectively) were greater in the NADGM than in normal-appearing white matter or cortex. APP-positive axonal spheroids were more often found in the NADGM than in the normal-appearing white matter (p=0.006). The iron content of NADGM was also significantly higher than that in cortical grey matter and normal-appearing white matter (p<0.001 and p<0.001, respectively).
APP, amyloid precursor protein; IBA-1, ionised calcium-binding adapter molecule 1; iNOS, inducible nitric oxide synthase; MS, multiple sclerosis.